EDGAR Filing Documents for 0001193125-13-292948

Form 8-K - Current report:

SEC Accession No. 0001193125-13-292948

Filing Date

2013-07-17

Accepted

2013-07-17 16:05:53

Documents

Period of Report

2013-07-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d570207d8k.htm	8-K	18235
2	EX-10.1	d570207dex101.htm	EX-10.1	16401
3	EX-10.2	d570207dex102.htm	EX-10.2	86903
	Complete submission text file	0001193125-13-292948.txt		123076

Mailing Address 7180 SW SANDBURG STREET, SUITE 100 TIGARD OR 97223

Business Address 7180 SW SANDBURG STREET, SUITE 100 TIGARD OR 97223 503-692-8001

BIOJECT MEDICAL TECHNOLOGIES INC (Filer) CIK: 0000810084 (see all company filings)